Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neuroectodermal Tumors 1Neuroblastoma 1Neoplasms, Neuroepithelial 1Neoplasms, Nerve Tissue 1Neoplasms 1Glioma 1Glioblastoma 1

Interventions

Temozolomide 2Oncolytic Virotherapy 2vorasidenib 1pembrolizumab 1pamiparib 1interferon gamma-1b 1cixutumumab 1Vorinostat 1Vincristine 1Valproic Acid 1Thiotepa 1Radiotherapy 1Radiation 1Peripheral Blood Stem Cell Transplantation 1ONC206 1Melphalan 1Maintenance Chemotherapy 1Lomustine 1Interleukin-12 1Interferon-gamma 1Immunotherapy 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Erlotinib Hydrochloride 1Cisplatin 1Busulfan 1Bone Marrow Transplantation 1Antibodies, Monoclonal 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroectodermal Tumors × Interleukin-12 × CNS × Clear all
NCT04388033 2020-06-09

Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 1/2 Unknown
10 enrolled
CNS

Glioblastoma, Glioma, Neoplasms, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Neoplasms, Neuroepithelial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡